Orhan N.Aslan M.Pekcan M.Orhan D.D.Bedir E.Ergun F.2019-10-272019-10-2720120378-8741https://doi.org/10.1016/j.jep.2011.10.027https://hdl.handle.net/11454/26711Ethnopharmacological relevance: Decoction of Juniperus oxycedrus subsp. oxycedrus L. (Cupressaceae) berries is used internally as tea and pounded fruits are consumed to lower blood glucose levels in Turkey. Aim of the study: To evaluate hypoglycaemic and antidiabetic activity of J. oxycedrus subsp. oxycedrus berries and to identify active compounds through bioactivity guided isolation technique. Material and methods: Hypoglycaemic effect of J. oxycedrus subsp. oxycedrus (Joso) berry extracts on oral administration was studied using in vivo models in normal, glucose-hyperglycaemic rats. Streptozotocin induced diabetic rats were used to examine antidiabetic activity of Joso extracts, subextracts, fractions, subfractions and shikimic acid (SA). Results: Through in vivo bioactivity-guided fractionation processes, shikimic acid, 4-O-ß-d-glucopyranosyl ferulic acid and oleuropeic acid-8-O-ß-d- glucopyranoside were isolated from the n-butanol subextract by silica gel and reverse phase column chromatography as the main active ingredient of the active subfraction. After 8 days administration of the major compound shikimic acid, blood glucose levels (24%), malondialdehyde levels in kidney tissues (63-64%) and liver enzymes (AST, ALT, ALP) of diabetic rats were decreased. Conclusion: Results indicated that Joso berry extract and its active constituents might be beneficial for diabetes and its complications. © 2011 Elsevier Ireland Ltd. All rights reserved.en10.1016/j.jep.2011.10.027info:eu-repo/semantics/closedAccessAntioxidantDiabetes mellitusFerulic acidHypoglycaemicJuniperus oxycedrus ssp. oxycedrus L. (Cupressaceae)Oleuropeic acidShikimic acidArticle139111011822063725Q1